Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology

Biochemical Journal

Volumn 398, Issue 1, 2006, Pages 83-95

  Silva, Patrícia N G ^a   Soares, Jamária A P ^a   Brasil, Bruno S A F ^a   Nogueira, Sarah V ^a   Andrade, Anderson A ^a,b   De Magalhães, José C ^a,c   Bonjardim, Marisa B ^a   Ferreira, Paulo C P ^a   Kroon, Erna G ^a   Bruna Romero, Oscar ^a   Bonjardim, Cláudio A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

^c CENTRO UNIVERSITÁRIO DE BELO HORIZONTE   (Brazil)

Author keywords

Cowpox virus; Early growth response 1 (EGR 1); Mitogen activated protein kinase extracellular signal regulated kinase kinase (MEK); Orthopoxvirus; Vaccinia virus; Virus host cell interaction

Indexed keywords

CELLS; DISEASES; DNA; GENES; GENETIC ENGINEERING; VIRUSES;

COWPOX VIRUS; EARLY GROWTH RESPONSE 1 (EGR-1); MITOGEN-ACTIVATED PROTEIN KINASE/EXTRACELLULAR-SIGNAL-REGULATED KINASE KINASE (MEK); ORTHOPOXVIRUS; VACCINIA VIRUS; VIRUS-HOST CELL INTERACTION;

VACCINES;

EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; COWPOX; GENE CONTROL; GENE SILENCING; GENE TRANSLOCATION; INFECTION; INHIBITION KINETICS; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; ORTHOPOXVIRUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS REPLICATION;

ANIMALS; BALB 3T3 CELLS; CELL NUCLEUS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COWPOX VIRUS; DNA, VIRAL; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE SILENCING; GENES, DOMINANT; GENES, IMMEDIATE-EARLY; MAP KINASE KINASE 1; MICE; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VERO CELLS; VIRUS REPLICATION;

COWPOX VIRUS; POXVIRIDAE; VACCINIA VIRUS;

EID: 33747161380     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20060509     Document Type: Article

References (52)

1. Moss, B. (1996) Poxviridae viruses and their replication. In Fields Virology, vol. 2 (Fields, B. N., Knipe, D. M. and Howley, P. M., eds.), 3rd edn, pp. 2637-2672, Lippincott-Raven Publishers, New York
2. Smith, G. L. and McFadden, G. (2002) Smallpox: anything to declare? Nat. Rev. Immunol. 2, 521-527
3. Lalani, A. S., Masters, J., Zeng, W., Barrett, J., Pannu, R., Everett, H., Arendt, C. W. and McFadden, G. (1999) Use of chemokine receptors by poxviruses. Science 286, 1968-1971
4. Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J., Nazarian, S. H., Lucas, A. and McFadden, G. (2003) Poxviruses and immune evasion. Annu. Rev. Immunol. 21, 377-423
5. Smith, G. L., Symons, J. A., Khanna, A., Vanderplasschen, A. and Alcami, A. (1997) Vaccinia virus immune evasion. Immunol. Rev. 159, 137-154
6. Alcami, A. (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3, 36-50
7. Beattie, E., Denzler, K. L., Tartaglia, J., Perkus, M. E., Paoletti, E. and Jacobs, B. L. (1995) Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69, 499-505
8. Smith, E. J., Marie, I., Prakash, A., Garcia-Sastre, A. and Levy, D. E. (2001) IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or IκB kinase but is blocked by vaccinia virus E3L protein. J. Biol. Chem. 276, 8951-8957
9. Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K. and O'Neill, L. A. (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 97, 10162-10167
10. Bonjardim, C. A. (2005) Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses - and viruses counteract IFN action. Microbes. Infect. 7, 569-578
11. Johnston, J. B., Barrett, J. W., Chang, W., Chung, C. S., Zeng, W., Masters, J., Mann, M., Wang, F., Cao, J. and McFadden, G. (2003) Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J. Virol. 77, 5877-5888
12. Wang, F., Ma, Y., Barrett, J. W., Gao, X., Loh, J., Barton, E., Virgin, H. W. and McFadden, G. (2004) Disruption of ERK-dependent type I interferon induction breaks the myxoma virus species barrier. Nat. Immunol. 5, 1266-1274
13. McFadden, G. (2005) Poxvirus tropism. Nat. Rev. Microbiol. 3, 201-213
14. Andrade, A. A., Silva, P. N., Pereira, A. C., De Sousa, L. P., Ferreira, P. C., Gazzinelli, R. T., Kroon, E. G., Ropert, C. and Bonjardim, C. A. (2004) The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem. J. 381, 437-446
15. de Magalhaes, J. C., Andrade, A. A., Silva, P. N., Sousa, L. P., Ropert, C., Ferreira, P. C., Kroon, E. G., Gazzinelli, R. T. and Bonjardim, C. A. (2001) A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J. Biol. Chem. 276, 38353-38360
16. Rosales, R., Sutter, G. and Moss, B. (1994) A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. Proc. Natl. Acad. Sci. U.S.A. 91, 3794-3798
17. Broyles, S. S., Liu, X., Zhu, M. and Kremer, M. (1999) Transcription factor YY1 is a vaccinia virus late promoter activator. J. Biol. Chem. 274, 35662-35667
18. Guerra, S., Lopez-Fernandez, L. A., Pascual-Montano, A., Munoz, M., Harshman, K. and Esteban, M. (2003) Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 77, 6493-6506
19. Wright, C. F., Hubbs, A. E., Gunasinghe, S. K. and Oswald, B. W. (1998) A vaccinia virus late transcription factor copurifies with a factor that binds to a viral late promoter and is complemented by extracts from uninfected HeLa cells. J. Virol. 72, 1446-1451
20. Hung, J. J., Chung, C. S. and Chang, W. (2002) Molecular chaperone Hsp90 is important for vaccinia virus growth in cells. J. Virol. 76, 1379-1390
21. Castro, A. P., Carvalho, T. M., Moussatche, N. and Damaso, C. R. (2003) Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles. J. Virol. 77, 9052-9068
22. Oh, J. and Broyles, S. S. (2005) Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes. J. Virol. 79, 12852-12860
23. Milbrandt, J. (1987) A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238, 797-799
24. Silverman, E. S. and Collins, T. (1999) Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154, 665-670
25. Liu, C., Rangnekar, V. M., Adamson, E. and Mercola, D. (1998) Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 5, 3-28
26. Sukhatme, V. P., Cao, X. M., Chang, L. C., Tsai-Morris, C. H., Stamenkovich, D., Ferreira, P. C., Cohen, D. R., Edwards, S. A., Shows, T. B., Curran, T. et al. (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53, 37-43
27. Khachigian, L. M., Lindner, V., Williams, A. J. and Collins, T. (1996) Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271, 1427-1431
28. Feng, W. H., Hong, G., Delecluse, H. J. and Kenney, S. C. (2004) Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J. Virol. 78, 1893-1902
29. Nilsson, T., Zetterberg, H., Wang, Y. C. and Rymo, L. (2001) Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. J. Virol. 75, 5796-5811
30. Tatarowicz, W. A., Martin, C. E., Pekosz, A. S., Madden, S. L., Rauscher, 3rd, F. J., Chiang, S. Y., Beerman, T. A. and Fraser, N. W. (1997) Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J. Neurovirol. 3, 212-224
31. Yang, Y., Dong, B., Mittelstadt, P. R., Xiao, H. and Ashwell, J. D. (2002) HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J. Biol. Chem. 277, 19482-19487
32. da Fonseca, F. G., Trindade, G. S., Silva, R. L., Bonjardim, C. A., Ferreira, P. C. and Kroon, E. G. (2002) Characterization of a vaccinia-like virus isolated in a Brazilian forest. J. Gen. Virol. 83, 223-228
33. Husain, M. and Moss, B. (2003) Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus. J. Virol. 77, 9008-9019
34. Joklik, W. K. (1962) The purification of four strains of poxvirus. Virology 18, 9-18
35. Locker, J. K., Kuehn, A., Schleich, S., Rutter, G., Hohenberg, H., Wepf, R. and Griffiths, G. (2000) Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV. Mol. Biol. Cell. 11, 2497-2511
36. De Sousa, L. P., Brasil, B. S., Silva, B. M., Freitas, M. H., Nogueira, S. V., Ferreira, P. C., Kroon, E. G. and Bonjardim, C. A. (2005) Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochem. Biophys. Res. Commun. 329, 237-245
37. Bonjardim, C. A. (1997) A mutant cell line partially responsive to both IFN-α and IFN-γ. Braz. J. Med. Biol. Res. 30, 41-50
38. Zimarino, V. and Wu, C. (1987) Induction of sequence-specific binding of Drosophila heat shock activator protein without protein synthesis. Nature (London) 327, 727-730
39. Horgan, A. M. and Stork, P. J. (2003) Examining the mechanism of ERK nuclear translocation using green fluorescent protein. Exp. Cell Res. 285, 208-220
40. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
41. Dykxhoorn, D. M., Novina, C. D. and Sharp, P. A. (2003) Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4, 457-467
42. Baroudy, B. M. and Moss, B. (1980) Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions. J. Biol. Chem. 255, 4372-4380
43. Broyles, S. S., Yuen, L., Shuman, S. and Moss, B. (1988) Purification of a factor required for transcription of vaccinia virus early genes. J. Biol. Chem. 263, 10754-10760
44. Shuman, S., Broyles, S. S. and Moss, B. (1987) Purification and characterization of a transcription termination factor from vaccinia virions. J. Biol. Chem. 262, 12372-12380
45. Gitlin, L., Karelsky, S. and Andino, R. (2002) Short interfering RNA confers intracellular antiviral immunity in human cells. Nature (London) 418, 430-434
46. Qin, X. F., An, D. S., Chen, I. S. and Baltimore, D. (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U.S.A. 100, 183-188
47. Randall, G., Grakoui, A. and Rice, C. M. (2003) Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100, 235-240
48. Ludwig, H., Mages, J., Staib, C., Lehmann, M. H., Lang, R. and Sutter, G. (2005) Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa cells: regulation of the virus life cycle and identification of differentially expressed host genes. J. Viral. 79, 2584-2596
49. Condit, R. C. and Niles, E. G. (2002) Regulation of viral transcription elongation and termination during vaccinia virus infection. Biochim. Biophys. Acta 1577, 325-336
50. Ruvkun, G., Wightman, B. and Ha, I. (2004) The 20 years it took to recognize the importance of tiny RNAs. Cell 116, S93-96
51. Takeda, K. and Akira, S. (2005) Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14
52. Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A. and O'Neill, L. A. (2003) The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197, 343-351